KetaMD is on a mission to change the face of mental health, providing safe, affordable and potentially life-changing at-home medical ketamine treatments. Prescribed by medical professionals and guided by registered nurses via our secure, HIPAA-compliant platform and mobile app, KetaMD is a safe and effective alternative for the millions of adults who suffer from depression, anxiety, and related mental health challenges. Ketamine, the only legal psychedelic, has been proven to produce rapid and robust results, even for those with treatment-resistant symptoms who don’t respond to traditional medications and treatments. We operate in a nascent and exciting market, that is revolutionizing how we treat mental health. KetaMD launched in Florida in August 2022, with plans to expand across the U.S. in the next 18-24 months.
KetaMD was recently acquired by Braxia Scientific, a medical research company with clinics across Canada, and a research division dedicated to the discovery and commercialization of novel drugs and delivery methods. Combining Braxia’s unprecedented scientific expertise within the field of mental health & psychedelics with KetaMD’s profitable commercialization model, our mission is to provide access to innovative mental health treatments to as many people as possible, identify and commercialize next-generation psychedelic medicines and educate the global market, consumers, and healthcare providers.